Autolus Therapeutics Plc (AUTL)
1.455
0.00 (0.00%)
USD |
NASDAQ |
Jun 09, 10:19
Autolus Therapeutics Shareholders Equity (Quarterly) : 108.83M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 207.90M |
| Cellectis SA | 59.92M |
| Akari Therapeutics Plc | 14.38M |
| Grifols SA | 6.289B |
| Evaxion AS | 13.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 527.06M |
| Total Liabilities (Quarterly) | 418.24M |
| Debt to Equity Ratio | 3.392 |
| Current Ratio | 5.758 |
| Net Debt Paydown Yield | -3.92% |